Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 20/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16752955 | 0.96 | ALK (1.00) | ALK | |
| SCHEMBL16752969 | 0.96 | ALK (1.00) | ALK | |
| SCHEMBL16752917 | 0.93 | ALK (0.91) | ALK | |
| SCHEMBL16752923 | 0.92 | ALK (1.00) | ALK | |
| SCHEMBL16752912 | 0.90 | ALK (0.85) | ALK | |
| SCHEMBL16752903 | 0.90 | ALK (1.00) | ALK | |
| SCHEMBL16752929 | 0.90 | ALK (1.00) | ALK | |
| SCHEMBL16752947 | 0.89 | ALK (1.00) | ALK | |
| SCHEMBL16769540 | 0.89 | ALK (1.00) | ALK | |
| SCHEMBL16769585 | 0.88 | ALK (0.85) | ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2883875-B1 | N2,N4-BIS(4-(PIPERAZINE-1-YL)PHENYL)PIRIMIDINE-2,4-DIAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER | KOREA RES INST CHEMICAL TECH (KR) | 2016-12-28 | — | — | EP | disclosed |
| EP-2883875-A1 | N2,N4-BIS(4-(PIPERAZINE-1-YL)PHENYL)PIRIMIDINE-2,4-DIAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER | Korea Reserach Institute Of Chemical Technology (KR) | 2015-06-17 | — | — | EP | disclosed |